Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT05095090

Study of Hospitalised Patients With Acute Respiratory Conditions

Study of Hospitalised Patients With Acute Respiratory Conditions — Recruiting • Cardiology / Cardiovascular • NCT05095090.

📅 06 Oct 2026 ⏱ 3 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT05095090
Sponsor
University of Leicester
Start
2022-02-02
ClinicaliQ Trial Snapshot
  • Study of Hospitalised Patients With Acute Respiratory Conditions — Recruiting • Cardiology / Cardiovascular • NCT05095090.
  • What is being tested: This observational study evaluates short- and long-term outcomes in hospitalised patients with acute respiratory conditions, including acute exacerbations of chronic lung disease, and identifies predictive factors for patient recovery.
  • Patient eligibility overview: The study includes adults admitted to hospital with acute respiratory conditions; specific inclusion/exclusion criteria would determine whether participants have primary acute respiratory illness, chronic lung disease exacerbations, or both.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The goal of this observational study is to learn about the short- and long-term outcomes of people admitted to hospital with an acute respiratory condition, including exacerbations of chronic lung disease, and to understand factors that may predict recovery, hospital readmission, length of hospital stay, and mortality. A group of people with chronic respiratory disease who are being followed in respiratory outpatient clinics and a healthy control group without lung disease will also take part. The main questions it aims to answer are: * Which clinical, physical, functional, and biological…

Eligibility Snapshot
  • (Core study participants) 1. Hospital admission with an acute respiratory diagnosis, or currently under the care of hospital respiratory outpatient services for a chronic respiratory disease
  • Participant is willing & able to give informed consent for participation in the study 3. Aged 18 years or above 4. Able (in the Investigators opinion) & willing to comply with all study requirements

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Finerenone for treating chronic heart failure with preserved or mildly reduced ejection fraction
Cardiology / Cardiovascular · 05 Aug 2026
Finerenone is recommended as an option for chronic heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF) and can be initiated…
View guideline →
Guideline
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
Cardiology / Cardiovascular · 30 Mar 2026
Covers rapid diagnosis and risk stratification for acute coronary syndromes (ACS) including STEMI and NSTEMI • Provides evidence-based recommendations for reperfusion strategies…
View guideline →
Guideline
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity
Cardiology / Cardiovascular · 07 May 2026
Semaglutide is recommended for adults with established cardiovascular disease and overweight/obesity to reduce major adverse cardiovascular events – consider prescribing as part…
View guideline →
Guideline
2024 ESC Guidelines for the Management of Atrial Fibrillation
Cardiology / Cardiovascular · 30 Mar 2026
Covers AF classification, stroke risk assessment (CHA2DS2-VASc), and bleeding risk (HAS-BLED) • Provides recommendations for rate vs rhythm control strategies • Addresses…
View guideline →
Clinical Brief
Weight-loss jabs will be offered on NHS for people at risk of further heart attacks
Cardiology / Cardiovascular · BBC Health · 31 Mar 2026
GLP-1 receptor agonists (weight-loss jabs) will now be offered on NHS to over 1 million people in England at high cardiovascular risk,…
View brief →
Clinical Brief
‘I was dead for 10 minutes, but lived to tell the tale’
Cardiology / Cardiovascular · BBC Health · 13 Oct 2026
Cardiac arrest survival is possible with rapid intervention: A patient in Spain survived 10 minutes of cardiac arrest, demonstrating the critical importance…
View brief →